StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for THRM yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-15 | $31.09 | $30.17 | -2.96% | 0.3M |
| 05-18 | $30.42 | $30.34 | -0.26% | 0.2M |
| 05-19 | $30.18 | $29.96 | -0.73% | 0.3M |
| 05-20 | $30.01 | $31.20 | +3.97% | 0.3M |
| 05-21 | $30.81 | $31.87 | +3.44% | 0.1M |
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the USA, China, South Korea, Germany, Japan, the Czech Republic, and other countries.
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $393.71M | $1.50B | $1.12B | $728.94M |
Operating Income | $11.29M | $82.70M | $64.93M | $41.07M |
Net Income | $4.22M | $18.29M | $15.30M | $477.00K |
EPS (Diluted) | $0.14 | $0.59 | $0.50 | $0.01 |
Total Assets | $1.43B | $1.40B | $1.38B | $1.36B |
Total Liabilities | $713.82M | $676.11M | $663.39M | $661.66M |
Cash & Equivalents | $177.40M | $160.83M | $154.25M | $128.30M |
Free Cash Flow OCF − CapEx | $-10.69M | $61.12M | $54.44M | $7.97M |
Shares Outstanding | 30.67M | 30.53M | 30.53M | 30.52M |
THRM is in the extended universe. We surface dollar-volume + price-change percentiles for every US-listed name, but the full 6-factor DNA breakdown (momentum, news, sentiment, flow, relative strength) is only computed on the curated 1137-name primary list.
DNA analysis is not available for this ticker.
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.